2020
DOI: 10.1155/2020/8890873
|View full text |Cite
|
Sign up to set email alerts
|

Dental Pulp Mesenchymal Stem Cells as a Treatment for Periodontal Disease in Older Adults

Abstract: Periodontal disease (PD) is one of the main causes of tooth loss and is related to oxidative stress and chronic inflammation. Although different treatments have been proposed in the past, the vast majority do not regenerate lost tissues. In this sense, the use of dental pulp mesenchymal stem cells (DPMSCs) seems to be an alternative for the regeneration of periodontal bone tissue. A quasi-experimental study was conducted in a sample of 22 adults between 55 and 64 years of age with PD, without uncontrolled syst… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(11 citation statements)
references
References 90 publications
0
11
0
Order By: Relevance
“…36 These and other experimental data present strong evidence that DPSCs have the potential to induce the formation of human dental tissues in vivo; however, clinical data were available for only a few human cases. 37 Thus, the present case report examined whether the transplantation of human DPSCs contributed to periodontal repair in a patient with a periodontal disease-induced infrabony defect.…”
Section: Discussionmentioning
confidence: 96%
“…36 These and other experimental data present strong evidence that DPSCs have the potential to induce the formation of human dental tissues in vivo; however, clinical data were available for only a few human cases. 37 Thus, the present case report examined whether the transplantation of human DPSCs contributed to periodontal repair in a patient with a periodontal disease-induced infrabony defect.…”
Section: Discussionmentioning
confidence: 96%
“…Resident dental MSCs are involved in both inflammatory response and dental tissue repair after trauma. The clinical protocols for applying dental MSCs for the treatment of periodontal and endodontic defects are currently developing [151][152][153]. Besides, due to their accessibility and functional properties, dental MSCs have an enormous potential for application beyond the dental field [23].…”
Section: Concluding Remarks and Future Perspectivementioning
confidence: 99%
“…The odontogenic abilities of hDPSCs are crucial for this physiological process [ 30 ]. Recently, clinical trials for hDPSC-mediated therapies have rapidly developed, and there is a high potential for using hDPSCs as a novel therapy for many diseases, such as periodontal disease [ 31 ], neurological diseases [ 32 ], and stroke [ 33 , 34 ]. However, there is no research available regarding the effect of EDA and its mutant on the odontogenic differentiation abilities of hDPSCs.…”
Section: Discussionmentioning
confidence: 99%